According to the research report titled ‘Global Antibiotics Market 2022-2028’, available with MarketStudyReport, global antibiotics market is anticipated to expand at a CAGR of 4.3% during the analysis timeframe to reach USD 57435 million by the end of 2028.

The expansion of global antibiotics market is attributed to increasing efforts of pharmaceutical manufacturers and drug developers to produce novel medicines focused on treating various infectious diseases.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4973452/

For the unversed, antibiotics are anti-bacterial drugs that prevent bacterial infection by making it hard for them to multiply and grow. They're also used to treat urinary tract infections, ear infections, pneumonia, skin infections, strep throat, sinus infections, and other illnesses.

Furthermore, growing prevalence of various infectious disorders such as tuberculosis, pneumonia, lower respiratory infections, and malaria, along with favorable government policies are expected to augment industry expansion in the coming years.

The business intelligence document examines key segments of the marketplace and evaluates them based on their current condition, size, share, and revenue. It also informs readers about the key drivers and restraining variables that participants in the global antibiotics market deals with.

Based on drug class, the industry is segregated into tetracyclines, penicillin, macrolides, fluoroquinolones, cephalosporins, carbapenems, aminoglycosides, and others.

In terms of action mechanism, the market is branched into protein inhibitors, DNA inhibitors, cell wall inhibitors, and others. On the basis of spectrum, the marketplace is bifurcated into narrow-spectrum antibiotics and broad-spectrum antibiotics. Speaking of route of administration, the industry is split into topical, oral, and others.

Considering the regional landscape, the major trends are studied across Asia Pacific, North America, and Europe.

Coming toward the competitive arena, Sanofi S.A., Pfizer Inc., Novartis International AG, Mylan N.V., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, and Abbott Laboratories are the leading players in global antibiotics market.